|Place of Origin:||China|
|Minimum Order Quantity:||unlimited|
|Packaging Details:||plastic drum/carton drum/bag/|
|Delivery Time:||3-10 working days|
|Synonym:||3-ANISONITRILE; 3-METHOXYBENZONITRILE; 3-CYANOANISOLE; M-METHOXYBENZONITRILE; Benzonitrile, 3-methoxy-||CAS No:||1527-89-5|
|Grade:||Pharmaceutical Grade||Appearance:||Colorless Or Pale Yellow Liquid|
|P/N#:||MBN.99P.N||Packaging:||200kgs/iron Drum With Plastic Lining|
1527-89-5 Pharmaceutical 3-Methoxy Benzonitrile For Tapentadol Intermediate
3-Methoxybenzonitrile, also known as 3-methoxy benzonitrile, m-methoxy benzonitrile, colorless or slightly yellow liquid.
Physical and Chemical Properties
Physical State: Clear liquid
Appearance: colorless - light yellow
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: 111.0 - 112.0 deg C @ 13.00mm
Freezing/Melting Point: 0 deg C
Autoignition Temperature: Not available.
Flash Point: 105 deg C ( 221.00 deg F)
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Solubility in water:
Specific Gravity/Density: 1.0890g/cm3
Molecular Formula: C8H7NO
Molecular Weight: 133.15
|Water||Quality standard||meets company specification|
Harmful by inhalation, in contact with skin and if swallowed.
Potential Health Effects
The toxicological properties of this material have not been investigated. Use appropriate procedures to prevent opportunities for direct contact with the skin or eyes and to prevent inhalation.
Stability and Reactivity
Chemical Stability: Stable under normal temperatures and pressures.
Conditions to Avoid: Not available.
Incompatibilities with Other Materials: Strong oxidizing agents.
Hazardous Decomposition Products: Nitrogen oxides, carbon monoxide, carbon dioxide, nitrogen.
Used as a pharmaceutical intermediate, it is an important intermediate of the new antipyretic analgesic - tapentadol. The drug is mainly used to relieve moderate and severe acute pain, especially for the relief of adults over 18 years of age. Its quick release tablets were approved by the US Food and Drug Administration (trade name: NUCNTA) in November 2008 to relieve moderate and severe acute pain;Its sustained-release tablets were approved for marketing in August 2012 (trade name: NUCYNTA ER) for the treatment of adult diabetic neuropathy (DPN) -related neuropathic pain.In addition, it also can participate in a variety of organic synthesis.
Store in a cool, dry place, avoid direct sunlight. Store in a tightly closed container.
Wear appropriate protective clothing and gloves.
Avoid contact with skin and eyes.
BeiLi was built in 1996 with an ISO certificate.In the past 20 years, we have grown up as a famous fine chemicals manufacturer of MBN 3-methoxybenzonitrile CAS 1527-89-5 in China. And we had established good business credit in UK, Netherlands, Germany, Norway, Italy, US, Japan, Korea,India, Thailand etc.
Any more questions, or interest about the product, feel free to contact us!
Contact Person: lick
Appearance: colorless or pale yellow liquid
Reach PR#: 05-2119085531-41-0000
Solubility: Decompose by water or alcohol; soluble in benzene
Synonym: EBC;2-ETHOXYBENZOYL CHLORIDE;O-ETHOXYBENZOYL CHLORIDE;2-Ethoxybenzoyl Chloride o-Ethoxybenzoyl Chloride;Benzoyl chloride, 2-ethoxy- (9CI);2-Ethoxybenzoyl chloride 98%;2-Ethoxybenzoyl chlo;Sildenafil Chloro IMpurity;Ethoxybenzoyl chlorid